Futura Medical (LON:FUM) Shares Up 6.8% – What’s Next?

Futura Medical plc (LON:FUM)’s share price rose 6.8% during mid-day trading on Monday. The company traded as high as GBX 0.20 and last traded at GBX 0.17. Approximately 26,431,033 shares were traded during trading, an increase of 148% from the average daily volume of 10,665,203 shares. The stock had previously closed at GBX 0.16.

Futura Medical Stock Performance

The stock has a 50 day moving average of GBX 0.26 and a 200-day moving average of GBX 0.53. The company has a market cap of £2.91 million, a PE ratio of -0.24 and a beta of 0.02.

Futura Medical (LON:FUM) last posted its quarterly earnings results on Tuesday, September 1st. The company reported GBX (0.20) earnings per share for the quarter. Futura Medical had a negative net margin of 158.21% and a negative return on equity of 152.42%. Equities research analysts forecast that Futura Medical plc will post 2.85 EPS for the current year.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.